Premium
Centessa Pharmaceuticals Plc (0ACX)
LSE
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-01 | Dr. Mario Alberto AccardiCEO & Director | -604,00 | 23,81k | Sale to Issuer | 39,42 | 243,28k | -0,25% |
| 2026-03-26 | Ms. Karen M. AndersonCPO | -41,08k | 908,36k | Derivative Exercise and Sale | 8,01 - 30,12 | 62,09k | - |
| 2026-03-26 | Dr. Gregory M. WeinhoffChief Business Officer | -24,00k | 627,55k | Derivative Exercise and Sale | 3,85 - 30,00 | 0,00 | - |
| 2026-03-16 | Ms. Karen M. AndersonCPO | -74,81k | 1,81M | Derivative Exercise and Sale | 4,01 - 28,21 | 62,09k | - |
| 2026-03-13 | Ms. Karen M. AndersonCPO | -109,40k | 2,43M | Derivative Exercise and Sale | 3,85 - 27,13 | 4,04k | - |
| 2026-03-13 | Ms. Karen M. AndersonCPO | -10,63k | 288,45k | Vente | 27,13 | 4,04k | -72,49% |
| 2026-03-13 | Dr. Gregory M. WeinhoffChief Business Officer | -73,20k | 1,93M | Vente | 26,17 - 27,16 | 0,00 | -100,00% |
| 2026-01-30 | Mr. Iqbal J. HussainChief Legal Officer, CCO & Company Secretary | -39,96k | 1,00M | Vente | 25,01 - 25,15 | 25,12k | -61,40% |
| 2026-02-01 | Mr. Iqbal J. HussainChief Legal Officer, CCO & Company Secretary | -7,78k | 191,15k | Sale to Issuer | 24,57 | 25,12k | -23,65% |
| 2026-02-01 | Dr. Gregory M. WeinhoffChief Business Officer | -14,16k | 347,86k | Sale to Issuer | 24,57 | 73,20k | -16,21% |
| 2026-02-01 | Dr. Mario Alberto AccardiCEO & Director | -2,92k | 71,62k | Sale to Issuer | 24,57 | 243,89k | -1,18% |
| 2026-02-01 | Ms. Karen M. AndersonCPO | -10,61k | 260,59k | Sale to Issuer | 24,57 | 72,72k | -12,73% |
| 2026-02-02 | Ms. Tia L. BushChief Technology & Quality Officer | -8,55k | 210,05k | Sale to Issuer | 24,57 | 84,15k | -9,22% |
| 2025-12-09 | Dr. Mario Alberto AccardiCEO & Director | -10,00k | 288,29k | Automatic Disposition | 28,70 - 29,21 | 178,80k | -5,30% |
| 2025-12-08 | Dr. Mario Alberto AccardiCEO & Director | -5,00k | 102,35k | Derivative Exercise and Sale | 9,53 - 30,00 | 188,80k | - |
| 2025-12-08 | Dr. Mario Alberto AccardiCEO & Director | -5,00k | 150,00k | Automatic Disposition | 30,00 | 188,80k | -2,58% |
| 2025-11-18 | General Atlantic Service Company, L.P.Société | -2,32M | 87,31M | Vente | 36,65 - 38,63 | 7,37M | -23,91% |
| 2025-11-17 | Mr. Iqbal J. HussainChief Legal Officer, CCO & Company Secretary | -6,00k | 130,80k | Derivative Exercise and Sale | 5,84 - 27,64 | 39,96k | - |
| 2025-11-17 | Ms. Tia L. BushChief Technology & Quality Officer | -40,00k | 743,20k | Derivative Exercise and Sale | 9,42 - 28,00 | 74,53k | - |
| 2025-11-12 | Ms. Tia L. BushChief Technology & Quality Officer | -40,00k | 663,20k | Derivative Exercise and Sale | 9,42 - 26,00 | 74,53k | - |
| 2025-11-01 | Dr. Mario Alberto AccardiCEO & Director | -593,00 | 14,77k | Sale to Issuer | 24,90 | 193,80k | -0,31% |
| 2025-10-27 | Dr. Mario Alberto AccardiCEO & Director | -5,00k | 84,95k | Derivative Exercise and Sale | 8,01 - 25,00 | 194,39k | - |
| 2025-10-27 | Dr. Mario Alberto AccardiCEO & Director | -3,00k | 75,00k | Automatic Disposition | 25,00 | 194,39k | -1,52% |
| 2025-09-24 | Ms. Tia L. BushChief Technology & Quality Officer | -35,00k | 510,30k | Derivative Exercise and Sale | 9,42 - 24,00 | 74,53k | - |
| 2025-09-16 | Dr. Mario Alberto AccardiCEO & Director | -8,17k | 174,85k | Automatic Disposition | 21,33 - 22,02 | 197,39k | -3,98% |
| 2025-09-15 | Mr. Iqbal J. HussainChief Legal Officer, CCO & Company Secretary | -6,00k | 96,06k | Derivative Exercise and Sale | 5,84 - 21,85 | 45,46k | - |
| 2025-09-09 | Ms. Tia L. BushChief Technology & Quality Officer | -49,79k | 611,76k | Derivative Exercise and Sale | 8,01 - 22,00 | 74,53k | - |
| 2025-09-09 | Mr. Iqbal J. HussainChief Legal Officer, CCO & Company Secretary | -40,00k | 606,50k | Derivative Exercise and Sale | 5,84 - 22,00 | 45,46k | - |
| 2025-09-09 | Dr. Mario Alberto AccardiCEO & Director | -2,00k | 40,00k | Automatic Disposition | 20,00 | 205,57k | -0,96% |
| 2025-09-09 | Dr. Mario Alberto AccardiCEO & Director | -5,00k | 59,95k | Derivative Exercise and Sale | 8,01 - 20,00 | 205,57k | - |
| 2025-08-15 | Mr. Iqbal J. HussainChief Legal Officer, CCO & Company Secretary | -6,00k | 68,34k | Derivative Exercise and Sale | 5,84 - 17,23 | 45,46k | - |
| 2025-08-01 | Dr. Mario Alberto AccardiCEO & Director | -597,00 | 10,25k | Sale to Issuer | 17,17 | 207,57k | -0,29% |
| 2025-07-29 | Dr. Mario Alberto AccardiCEO & Director | -8,32k | 126,75k | Automatic Disposition | 15,23 | 208,16k | -3,84% |
| 2025-07-25 | Dr. Gregory M. WeinhoffChief Business Officer | -10,00k | 117,10k | Derivative Exercise and Sale | 3,85 - 15,56 | 60,24k | - |
| 2025-07-21 | Dr. Saurabh SahaInitié | -55,00k | 663,85k | Derivative Exercise and Sale | 3,85 - 15,92 | 45,17k | - |
| 2025-07-15 | Mr. Iqbal J. HussainChief Legal Officer, CCO & Company Secretary | -6,00k | 54,53k | Derivative Exercise and Sale | 5,84 - 14,93 | 45,46k | - |
| 2025-06-25 | Dr. Gregory M. WeinhoffChief Business Officer | -10,00k | 100,14k | Derivative Exercise and Sale | 3,85 - 13,86 | 60,24k | - |
| 2025-06-24 | Mr. Iqbal J. HussainChief Legal Officer, CCO & Company Secretary | -12,00k | 98,14k | Derivative Exercise and Sale | 5,84 - 14,02 | 46,46k | - |
| 2025-06-24 | Dr. Mario Alberto AccardiCEO & Director | -15,00k | 152,25k | Derivative Exercise and Sale | 3,85 - 14,00 | 216,49k | - |
| 2025-06-20 | Dr. Saurabh SahaInitié | -55,00k | 483,08k | Derivative Exercise and Sale | 3,85 - 12,63 | 45,17k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
